The Impact of Clinical Pharmacist Diabetes Education on Medication Adherence in Patients with Type 2 Diabetes Mellitus: An Interventional Study from Khartoum, Sudan

Author:

Badi Safaa1,Suliman Sara Zainelabdein1,Almahdi Rayan1,Aldomah Mohammed A.1,Marzouq Mohamed ELsir1ORCID,Ibrahim Eiman Eltayeb M.1,Ahmed Musaab2,Ahmed Mohamed H.34,Elkheir Habab Khalid15ORCID,Ibrahim Mohamed Izham Mohamed6ORCID

Affiliation:

1. Department of Clinical Pharmacy, Faculty of Pharmacy, Omdurman Islamic University, Khartoum 14415, Sudan

2. College of Medicine, Ajman University, Ajman P.O. Box 346, United Arab Emirates

3. Department of Medicine and HIV Metabolic Clinic, Milton Keynes University Hospital NHS Foundation Trust, Eaglestone, Milton Keynes MK6 5LD, UK

4. Department of Geriatric Medicine, Milton Keynes University Hospital NHS Foundation Trust, Eaglestone, Milton Keynes MK6 5LD, UK

5. Department of Clinical Pharmacy, University of Science and Technology, Khartoum 14411, Sudan

6. Department of Clinical Pharmacy and Practice, College of Pharmacy, QU Health, Qatar University, Doha P.O. Box 2713, Qatar

Abstract

Background: Continuous therapeutic care with good medication adherence is the cornerstone of management of all chronic diseases including diabetes. This study aimed to evaluate the impact of clinical pharmacist intervention on the medication adherence in individuals with type 2 diabetes (T2DM). Methods: This was a randomized, double-blind, controlled trial conducted at a diabetes clinic located at Omdurman Military Hospital, Sudan. Individuals with T2DM attending the diabetes clinic within 1 year were selected. The sample size was 364 participants (182 control and 182 interventional group). We used a pre-structured standardized questionnaire and checklist to collect the data. Data were analyzed by using the Statistical Package for the Social Sciences (SPSS) (version 28). Results: Majority, 76.4% (n = 278) were females, and they consisted of 80.8% (n = 147) of the interventional group and 72% of the controls. The mean age of the interventional group was 54.5 (±10) years; 31.9% (n = 58) of the interventional group had diabetes for 6–10 years, compared with 26.4% (n = 48) of the control group. Among the control group, the mean adherence score was 6.8 (±1.7) at baseline and it was 6.7 (±1.6) at the end of the study (p < 0.001), while in the interventional group, the mean adherence score was 6.8 (±1.7) at baseline and it was 7.4 (±1.5) at the end of the study (p < 0.001). Conclusion: Adherence score among the intervention group was increased significantly from baseline to the end of the study when compared to the control group.

Publisher

MDPI AG

Reference35 articles.

1. World Health Organization (WHO) (2021, July 01). ‘Diabetes’, WHO. Available online: https://www.who.int/health-topics/diabetes#tab=tab_1.

2. Diabetic kidney disease: Pathophysiology and therapeutic targets;Atta;J. Diabetes Res.,2015

3. (2019). IDF Diabetes Atlas, International Diabetes Federation. [9th ed.].

4. Adherence to therapies in patients with type 2 diabetes;Dilla;Diabetes Ther.,2013

5. Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review;Monnette;Pharmacoeconomics,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3